Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17

2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter’s Fiver Forces Analysis 42

3 Segmentation of North America Market by Offering 46
3.1 Market Overview by Offering 46
3.2 CRISPR Products 48
3.2.1 Kits & Enzymes 50
3.2.2 Databases & Libraries 51
3.2.3 Design Tools 52
3.2.4 Antibodies 53
3.2.5 CRISPR Plasmid & Vector 54
3.2.6 Other Products 55
3.3 CRISPR Services 56
3.3.1 gRNA Design & Vector Construction 58
3.3.2 Cell Line Engineering 59
3.3.3 Microbial Gene Editing 60
3.3.4 DNA Synthesis 61
3.3.5 Other Services 62

4 Segmentation of North America Market by Application 63
4.1 Market Overview by Application 63
4.2 Biomedical Research & Therapy 65
4.2.1 Gene Therapy 67
4.2.2 Drug Discovery 68
4.2.3 Diagnostics 69
4.2.4 Other Biomedical Applications 70
4.3 Agriculture 71
4.4 Industrial Use 72
4.5 Other Applications 73

5 Segmentation of North America Market by End User 74
5.1 Market Overview by End User 74
5.2 Pharmaceutical Companies 76
5.3 Biotechnology Companies 77
5.4 Academic Institutions & Research Centers 78
5.5 Other End Users 79

6 North America Market 2021-2031 by Country 80
6.1 Overview of North America Market 80
6.2 U.S. 83
6.3 Canada 86
6.4 Mexico 88

7 Competitive Landscape 89
7.1 Overview of Key Vendors 90
7.2 New Product Launch, Partnership, Investment, and M&A 94
7.3 Company Profiles 95
Abcam, Inc. 95
Agilent Technologies, Inc. 97
Applied StemCell, Inc. 98
Caribou Biosciences, Inc. 99
Cellecta, Inc. 100
CRISPR Therapeutics AG 101
Editas Medicine, Inc. 102
GeneCopoeia, Inc. 103
GeneScript Biotech Corporation 104
Horizon Discovery Group PLC 105
Integrated DNA Technologies, Inc. 106
Intellia Therapeutics Inc. 107
Lonza Group Ltd. 108
Merck KGaA 109
New England Biolabs, Inc. 110
Origene Technologies, Inc. 111
Rockland Immunochemicals, Inc. 112
Synthego Corporation 113
System Biosciences LLC 114
Takara Bio, Inc. 115
Thermo Fisher Scientific, Inc. 116
ToolGen, Inc. 117
RELATED REPORTS 118



List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. North America CRISPR Gene Editing Market, 2021-2031, $ mn 19
Figure 5. Categories of CRISPR-Cas Systems 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of North America CRISPR Gene Editing Market 26
Figure 8. Leading Causes of Death in the World, 2019-2020, million 32
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 33
Figure 11. Primary Restraints and Impact Factors of North America CRISPR Gene Editing Market 35
Figure 12. Investment Opportunity Analysis 39
Figure 13. Porter’s Fiver Forces Analysis of North America CRISPR Gene Editing Market 42
Figure 14. Breakdown of North America CRISPR Gene Editing Market by Offering, 2021-2031, % of Revenue 47
Figure 15. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 47
Figure 16. North America CRISPR Gene Editing Market by Offering: CRISPR Products, 2021-2031, $ mn 48
Figure 17. North America CRISPR Gene Editing Market by CRISPR Products: Kits & Enzymes, 2021-2031, $ mn 50
Figure 18. North America CRISPR Gene Editing Market by CRISPR Products: Databases & Libraries, 2021-2031, $ mn 51
Figure 19. North America CRISPR Gene Editing Market by CRISPR Products: Design Tools, 2021-2031, $ mn 52
Figure 20. North America CRISPR Gene Editing Market by CRISPR Products: Antibodies, 2021-2031, $ mn 53
Figure 21. North America CRISPR Gene Editing Market by CRISPR Products: CRISPR Plasmid & Vector, 2021-2031, $ mn 54
Figure 22. North America CRISPR Gene Editing Market by CRISPR Products: Other Products, 2021-2031, $ mn 55
Figure 23. North America CRISPR Gene Editing Market by Offering: CRISPR Services, 2021-2031, $ mn 56
Figure 24. North America CRISPR Gene Editing Market by CRISPR Services: gRNA Design & Vector Construction, 2021-2031, $ mn 58
Figure 25. North America CRISPR Gene Editing Market by CRISPR Services: Cell Line Engineering, 2021-2031, $ mn 59
Figure 26. North America CRISPR Gene Editing Market by CRISPR Services: Microbial Gene Editing, 2021-2031, $ mn 60
Figure 27. North America CRISPR Gene Editing Market by CRISPR Services: DNA Synthesis, 2021-2031, $ mn 61
Figure 28. North America CRISPR Gene Editing Market by CRISPR Services: Other Services, 2021-2031, $ mn 62
Figure 29. Breakdown of North America CRISPR Gene Editing Market by Application, 2021-2031, % of Sales Revenue 64
Figure 30. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 64
Figure 31. North America CRISPR Gene Editing Market by Application: Biomedical Research & Therapy, 2021-2031, $ mn 65
Figure 32. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Gene Therapy, 2021-2031, $ mn 67
Figure 33. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Drug Discovery, 2021-2031, $ mn 68
Figure 34. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Diagnostics, 2021-2031, $ mn 69
Figure 35. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Other Biomedical Applications, 2021-2031, $ mn 70
Figure 36. North America CRISPR Gene Editing Market by Application: Agriculture, 2021-2031, $ mn 71
Figure 37. North America CRISPR Gene Editing Market by Application: Industrial Use, 2021-2031, $ mn 72
Figure 38. North America CRISPR Gene Editing Market by Application: Other Applications, 2021-2031, $ mn 73
Figure 39. Breakdown of North America CRISPR Gene Editing Market by End User, 2021-2031, % of Sales Revenue 75
Figure 40. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 75
Figure 41. North America CRISPR Gene Editing Market by End User: Pharmaceutical Companies, 2021-2031, $ mn 76
Figure 42. North America CRISPR Gene Editing Market by End User: Biotechnology Companies, 2021-2031, $ mn 77
Figure 43. North America CRISPR Gene Editing Market by End User: Academic Institutions & Research Centers, 2021-2031, $ mn 78
Figure 44. North America CRISPR Gene Editing Market by End User: Other End Users, 2021-2031, $ mn 79
Figure 45. Breakdown of North America CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue 81
Figure 46. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 82
Figure 47. U.S. CRISPR Gene Editing Market, 2021-2031, $ mn 84
Figure 48. Canada CRISPR Gene Editing Market, 2021-2031, $ mn 86
Figure 49. CRISPR Gene Editing Market in Mexico, 2021-2031, $ mn 88
Figure 50. Growth Stage of North America CRISPR Gene Editing Industry over the Forecast Period 90

List of Tables

List of Tables:

Table 1. Snapshot of North America CRISPR Gene Editing Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 23
Table 3. Developing Roadmap of CRISPR Technology 27
Table 4. Private and Public Companies Investment in CRISPR Technology 28
Table 5. Comparison of CRISPR with Other Gene Editing Technologies 31
Table 6. World Health Spending by Region, $ bn, 2013-2020 34
Table 7. Main Product Trends and Market Opportunities in North America CRISPR Gene Editing Market 38
Table 8. North America CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 46
Table 9. North America CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn 49
Table 10. North America CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn 50
Table 11. North America CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn 57
Table 12. North America CRISPR Gene Editing Market by Application, 2021-2031, $ mn 63
Table 13. North America CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn 66
Table 14. North America CRISPR Gene Editing Market by End User, 2021-2031, $ mn 74
Table 15. North America CRISPR Gene Editing Market by Country, 2021-2031, $ mn 81
Table 16. U.S. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 85
Table 17. U.S. CRISPR Gene Editing Market by Application, 2021-2031, $ mn 85
Table 18. U.S. CRISPR Gene Editing Market by End User, 2021-2031, $ mn 85
Table 19. Canada CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 87
Table 20. Canada CRISPR Gene Editing Market by Application, 2021-2031, $ mn 87
Table 21. Canada CRISPR Gene Editing Market by End User, 2021-2031, $ mn 87
Table 22. Mexico CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 89
Table 23. Mexico CRISPR Gene Editing Market by Application, 2021-2031, $ mn 89
Table 24. Mexico CRISPR Gene Editing Market by End User, 2021-2031, $ mn 89
Table 25. Breakdown of World Market by Key Vendor, 2021, % 92
Table 26. Abcam, Inc.: Company Snapshot 95
Table 27. Abcam, Inc.: Business Segmentation 96
Table 28. Abcam, Inc.: Product Portfolio 96